Testing effectiveness (Phase 2)WithdrawnNCT00025051What this trial is testingCelecoxib in Preventing Skin CancerWho this might be right forNon-melanomatous Skin Cancer National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00030498What this trial is testingErlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more National Cancer Institute (NCI) 75
Early research (Phase 1)Study completedNCT00045006What this trial is testingSuberoylanilide Hydroxamic Acid in Treating Patients With Advanced CancerWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT00851253What this trial is testingStereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck CancerWho this might be right forHead and Neck Cancer Boston Medical Center 12
Early research (Phase 1)Study completedNCT00004065What this trial is testingChemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+9 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00492089What this trial is testingBevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck CancerWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Meningioma+84 more National Cancer Institute (NCI) 11
Not applicableStudy completedNCT00068497What this trial is testingGefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung CancerWho this might be right forAnaplastic Thyroid CancerInsular Thyroid CancerMetastatic Parathyroid Cancer+83 more National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00101348What this trial is testingErlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more National Cancer Institute (NCI) 66
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT00019331What this trial is testingVaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsWho this might be right forColorectal CancerEndometrial CancerHead and Neck Cancer+6 more National Cancer Institute (NCI)
Not applicableStudy completedNCT01155609What this trial is testingL-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck CancerWho this might be right forMucositisOral Complications of ChemotherapyOral Complications of Radiation Therapy+65 more University of Washington 10
Not applicableStudy completedNCT00896896What this trial is testingImmunoreactivity to Cetuximab in Cancer PatientsWho this might be right forColorectal CancerHead and Neck Cancer Vanderbilt-Ingram Cancer Center 538
Early research (Phase 1)Study completedNCT00019110What this trial is testingVaccine Therapy in Treating Patients With Advanced or Recurrent CancerWho this might be right forAnal CancerCervical CancerEsophageal Cancer+3 more National Cancer Institute (NCI)
Early research (Phase 1)Active Not RecruitingNCT04616248What this trial is testingIn Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid TumorsWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaPrognostic Stage IV Breast Cancer AJCC v8+10 more University of Southern California 14
Testing effectiveness (Phase 2)Study completedNCT00448552What this trial is testingOxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck CancerWho this might be right forHead and Neck Cancer University of Miami 30
Not applicableStudy completedNCT00002520What this trial is testingPhysician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+7 more Eastern Cooperative Oncology Group 434
Early research (Phase 1)Study completedNCT00089362What this trial is testingAlvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsWho this might be right forMale Breast CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+73 more National Cancer Institute (NCI) 30
Not applicableEnded earlyNCT01096381What this trial is testingPotential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid TumorWho this might be right forBreast CancerCardiovascular ComplicationsColorectal Cancer+6 more Vanderbilt-Ingram Cancer Center 8
Post-approval studies (Phase 4)Study completedNCT06880848What this trial is testingSonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in ChinaWho this might be right forCarcinoma, Basal Cell (BCC) Jemincare 160
Early research (Phase 1)Active Not RecruitingNCT03816332What this trial is testingTacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic CancersWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+18 more National Cancer Institute (NCI) 12